BORIS/CTCFL‐mediated chromatin accessibility alterations promote a pro‐invasive transcriptional signature in melanoma cells
Article in Pigment Cell & Melanoma Research (April 2023)
The most recent citing publications are shown below. View all 97 publications that cite this research output on Dimensions.
A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors
Article in International Journal of Molecular Sciences (March 2023)
Molecular principles of tissue invasion and metastasis
Article in American Journal of Physiology - Cell Physiology (March 2023)